APPBP2 Activators
APPBP2, or Amyloid Beta Precursor Protein Binding Protein 2, plays a pivotal role in cellular processes, acting as an important mediator in the regulation of microtubule dynamics and intracellular trafficking. This protein is involved in the binding to the amyloid precursor protein (APP), a critical player in the pathogenesis of Alzheimer's disease, yet its functions extend beyond this interaction, suggesting a broader role in neurobiological processes and cellular homeostasis. APPBP2's involvement in the stabilization of microtubules and participation in signaling pathways underscores its significance in maintaining cellular architecture and facilitating the precise delivery of cellular components to their designated locations within the cell. Its interaction with other proteins, such as PAT1, further illustrates its role in the post-transcriptional regulation of gene expression, highlighting its multifaceted functions in cellular biology.
The activation of APPBP2 involves intricate cellular signaling pathways that regulate its interaction with other proteins and its participation in cellular processes. Activation can be driven by changes in cellular conditions that trigger post-translational modifications, altering its conformation and enabling it to interact with specific partners, such as APP and microtubules. These modifications can include phosphorylation, ubiquitination, or sumoylation, each serving to modulate its activity and specificity for interaction with target proteins. Furthermore, the cellular localization of APPBP2, which can be influenced by signaling pathways responding to extracellular cues, dictates its availability to interact with key proteins and participate in crucial cellular functions. This spatial and temporal regulation of APPBP2 activity ensures that its functions are carried out in a highly controlled manner, enabling the cell to respond dynamically to internal and external stimuli. Through these mechanisms, APPBP2 contributes to the complex orchestration of cellular activities, playing a key role in maintaining cellular integrity and responding to the ever-changing cellular environment.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA functions as a diacylglycerol analog to activate protein kinase C (PKC). The activation of PKC leads to subsequent phosphorylation events that can enhance the activity of APPBP2, particularly in pathways associated with cell cycle regulation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin stimulates adenylate cyclase, leading to increased cAMP levels. Elevated cAMP activates PKA, which can phosphorylate proteins including those that interact with APPBP2, thereby enhancing APPBP2's role in cellular signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
As a calcium ionophore, ionomycin increases intracellular calcium concentrations, which can activate calcium-dependent protein kinases. These kinases may indirectly increase APPBP2 activity through phosphorylation of associated proteins. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that can modulate the activity of various kinases, possibly leading to reduced competition for APPBP2 binding sites on target proteins, thus enhancing APPBP2's functional interactions within cells. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which modulates the PI3K/Akt pathway. By inhibiting this pathway, LY294002 could lead to alterations in downstream proteins that interact with APPBP2, enhancing its activity in processes such as protein trafficking. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
D-erythro-Sphingosine-1-phosphate acts on its receptors to initiate signaling cascades that can lead to actin cytoskeletal rearrangements, potentially affecting proteins associated with APPBP2 and enhancing its activity in cytoskeletal organization. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits sarcoplasmic/endoplasmic reticulum Ca2+-ATPases (SERCAs), leading to increased cytosolic calcium levels. This can activate calcium-dependent signaling proteins that interact with APPBP2 to enhance its cellular functions. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor that, paradoxically, can enhance APPBP2 activity by inhibiting kinases that compete with APPBP2 for substrate binding or by altering the phosphorylation status of APPBP2-associated proteins. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which can modify the cellular stress response and potentially enhance APPBP2 function by influencing proteins that are regulated by stress-activated pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can increase the availability of tyrosine-phosphorylated proteins for APPBP2 interactions, enhancing the functional activity of APPBP2 in signaling pathways where tyrosine phosphorylation is relevant. | ||||||